Firstword Pharma shares news of Ilyas awarded EU patent

  Positive results from Ilya’s Phase I trial

  Ilya Pharma extends research collaboration with Uppsala University

  The developments of ILP100 as a new-to-the world drug candidate in cell-and gene therapy featured in Authority Magazine

  Close up with CEO Evelina Vågesjö in Nordic Life Science Magazine #4

  Immunology week hosted by Swedish TV

Immunology week hosted by Swedish TV, Malou efter 10. Mia Phillipson, Professor in physiology at Uppsala University and co-founder of Ilya Pharma gives an update of what immune cells do in the body during homeostasis and how they heal wounds in skin and mucosa. In Swedish.

  Completed recruitment in phase I study for ILP100-Topical published in First Word Pharma

  First Word Pharma shares news about the first granted US patent for the ILP-technolgy

  Co-founder of Ilya Pharma shortlisted for pioneering achievements in bringing game-changing innovation to clinical proof of concept.

Twenty-one of the most talented and inspiring women entrepreneurs in Europe and beyond are in the shortlist for the EU Prize for Women Innovators 2020. The prize celebrates the outstanding achievements of female entrepreneurs running innovative companies and is funded by the EU’s Horizon 2020 programme for research and innovation. This year’s finalists are pioneering game-changing innovations across a wide range of industries and help combat global challenges. The winners of the EU Prize for Women Innovators 2020 will be announced at the European Research and Innovation Days taking place on 22-24 September 2020. At the same event, the Commission will award the European Capital of Innovation 2020, the EIC Horizon Prize for Affordable High-Tech for Humanitarian Aid, and the Horizon Impact Award 2020.

  Ilya Pharma Awarded 5.3 million EUR